Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Home

Showing results (121-130 of 231) with videos related to

Pageof 24
Sort By:
Diabetes Research and Clinical Practice|October 15, 2013
The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: results from the A₁chieve observational studyPhilip D Home, Zafar A Latif, Guillermo González-Gálvez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 31, 2014
Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve studyIssam Hajjaji, Siddharth Shah, Yuxiu Li, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1990
Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulinJ C Thow, A B Johnson, S Marsden, et al.
Diabetologia|October 1, 1985
Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patientsJ T Jimenez, S Walford, P D Home, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 4, 2007
A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetesP D Home, C J Bailey, J Donaldson, et al.
Diabetes, Obesity & Metabolism|April 22, 2020
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trialGeremia B Bolli, Wolfgang Landgraf, Zsolt Bosnyak, et al.
Diabetes Care|September 1, 1982
A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSIIP D Home, B Capaldo, J M Burrin, et al.
The Journal of Clinical Investigation|March 1, 1993
Metabolic handling of orally administered glucose in cirrhosisY T Kruszynska, A Meyer-Alber, F Darakhshan, et al.
Diabetologia|October 1, 1986
Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitusY T Kruszynska, G Petranyi, P D Home, et al.
International Journal of Clinical Practice|October 16, 2010
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database studyJ Gordon, R D Pockett, A P Tetlow, et al.
Pageof 24

Showing results (121-130 of 231) with videos related to

Sort By:
Pageof 24
Diabetes Research and Clinical Practice|October 15, 2013
The effectiveness and safety of beginning insulin aspart together with basal insulin in people with type 2 diabetes in non-Western nations: results from the A₁chieve observational studyPhilip D Home, Zafar A Latif, Guillermo González-Gálvez, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 31, 2014
Safety, tolerability, and efficacy of insulin aspart in people with type 2 diabetes, as biphasic insulin aspart or with Basal insulin: findings from the multinational, non-interventional a1chieve studyIssam Hajjaji, Siddharth Shah, Yuxiu Li, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 1, 1990
Morphology of palpably abnormal injection sites and effects on absorption of isophane(NPH) insulinJ C Thow, A B Johnson, S Marsden, et al.
Diabetologia|October 1, 1985
Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patientsJ T Jimenez, S Walford, P D Home, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 4, 2007
A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetesP D Home, C J Bailey, J Donaldson, et al.
Diabetes, Obesity & Metabolism|April 22, 2020
Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C-peptide levels in insulin-naïve people with type 2 diabetes: A post hoc analysis of the EDITION 3 trialGeremia B Bolli, Wolfgang Landgraf, Zsolt Bosnyak, et al.
Diabetes Care|September 1, 1982
A crossover comparison of continuous subcutaneous insulin infusion (CSII) against multiple insulin injections in insulin-dependent diabetic subjects: improved control with CSIIP D Home, B Capaldo, J M Burrin, et al.
The Journal of Clinical Investigation|March 1, 1993
Metabolic handling of orally administered glucose in cirrhosisY T Kruszynska, A Meyer-Alber, F Darakhshan, et al.
Diabetologia|October 1, 1986
Muscle enzyme activity and insulin sensitivity in type 1 (insulin-dependent) diabetes mellitusY T Kruszynska, G Petranyi, P D Home, et al.
International Journal of Clinical Practice|October 16, 2010
A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database studyJ Gordon, R D Pockett, A P Tetlow, et al.
Pageof 24